Article: Cape Drugs, Annapolis, MD, July 11 (CDER).(HUMAN DRUGS & DIETARY SUPPLEMENTS)

On Feb. 25, a Special Agent with FDA's Office of Criminal Investigations determined that Cape Drugs was compounding drugs containing domperidone--an unapproved drug, which is not recognized to be safe and effective.

Domperidone has been used by women who are pregnant or nursing to increase milk production, because it may increase the secretion of prolactin, a hormone that is needed for lactation.

According to FDA's Compliance Policy Guide, however, firms cannot compound finished drugs from bulk active ingredients that are not components of FDA-approved drugs without an FDA-sanctioned investigational NDA.

The agency also determined that this ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!